Document Type
Report
Publication Date
6-21-2002
Abstract
This paper explores the complex connections among intellectual property protection, competition, and access to affordable prescription drug products. It focuses on several provisions of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman) and discusses the debate swirling around its reform. An overview of landmark intellectual property laws and a description of the generic drug approval process are also included.
Recommended Citation
Strongin, Robin J., "Hatch-Waxman, Generics, and Patents: Balancing Prescription Drug Innovation, Competition, and Affordability" (2002). National Health Policy Forum. Paper 94.
https://hsrc.himmelfarb.gwu.edu/sphhs_centers_nhpf/94
Open Access
yes
Included in
Community Health and Preventive Medicine Commons, Health and Medical Administration Commons, Health Law and Policy Commons, Health Services Administration Commons, Health Services Research Commons